Laryngeal neuroendocrine tumors (NETs) are rare tumors that arise from neuroendocrine cells in the larynx (voice box). These tumors can be benign or malignant, and they can cause a variety of symptoms, including hoarseness, difficulty breathing, and pain. Treatment for laryngeal NETs typically involves surgery, radiation therapy, and/or chemotherapy.

The most common symptom of a laryngeal neuroendocrine tumor is hoarseness or a change in the voice. Other symptoms may include difficulty breathing, coughing, throat pain, and a lump in the neck.

The exact cause of laryngeal neuroendocrine tumors is unknown. However, some risk factors have been identified, including smoking, exposure to certain chemicals, and a family history of neuroendocrine tumors.

The treatment for laryngeal neuroendocrine tumors depends on the size and location of the tumor, as well as the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, and targeted therapy. Surgery is the most common treatment for laryngeal neuroendocrine tumors and may involve removing the tumor and some surrounding tissue. Radiation therapy may be used to shrink the tumor before or after surgery. Chemotherapy and targeted therapy may also be used to shrink the tumor or to reduce the risk of recurrence.

1. Smoking
2. Excessive alcohol consumption
3. Exposure to certain chemicals, such as asbestos
4. Exposure to radiation
5. Family history of laryngeal cancer
6. Chronic laryngitis
7. Gastroesophageal reflux disease (GERD)
8. Human papillomavirus (HPV) infection
9. Age (over 50)
10. Male gender

There is no known cure for laryngeal neuroendocrine tumors. Treatment options may include surgery, radiation therapy, chemotherapy, and targeted therapy. Depending on the type and stage of the tumor, a combination of these treatments may be recommended. Medications may also be prescribed to help manage symptoms and side effects of treatment.